- Home
- NPWR vs KURA Comparison
NPWR vs KURA Comparison
Compare NPWR & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- KURA
- Stock Information
- Founded
- NPWR 2010
- KURA 2014
- Country
- NPWR United States
- KURA United States
- Employees
- NPWR N/A
- KURA N/A
- Industry
- NPWR Industrial Machinery/Components
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPWR Energy
- KURA Health Care
- Exchange
- NPWR Nasdaq
- KURA Nasdaq
- Market Cap
- NPWR 726.1M
- KURA 592.7M
- IPO Year
- NPWR N/A
- KURA N/A
- Fundamental
- Price
- NPWR $1.98
- KURA $5.90
- Analyst Decision
- NPWR Buy
- KURA Strong Buy
- Analyst Count
- NPWR 2
- KURA 10
- Target Price
- NPWR $4.50
- KURA $25.50
- AVG Volume (30 Days)
- NPWR 807.2K
- KURA 1.6M
- Earning Date
- NPWR 05-12-2025
- KURA 05-01-2025
- Dividend Yield
- NPWR N/A
- KURA N/A
- EPS Growth
- NPWR N/A
- KURA N/A
- EPS
- NPWR N/A
- KURA N/A
- Revenue
- NPWR $250,000.00
- KURA $53,883,000.00
- Revenue This Year
- NPWR $308.00
- KURA $44.32
- Revenue Next Year
- NPWR $1,811.08
- KURA $173.73
- P/E Ratio
- NPWR N/A
- KURA N/A
- Revenue Growth
- NPWR 42.86
- KURA N/A
- 52 Week Low
- NPWR $1.97
- KURA $5.41
- 52 Week High
- NPWR $14.28
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- NPWR 25.23
- KURA 38.78
- Support Level
- NPWR $2.49
- KURA $5.48
- Resistance Level
- NPWR $2.48
- KURA $6.11
- Average True Range (ATR)
- NPWR 0.23
- KURA 0.39
- MACD
- NPWR 0.14
- KURA 0.01
- Stochastic Oscillator
- NPWR 2.72
- KURA 31.82
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system which it refers to as the "NET Power Cycle is designed to produce clean, reliable and low-cost electricity from natural gas while capturing virtually all atmospheric emissions.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.